Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • USFDA inspection

    Tag: USFDA inspection

    You Searched For "USFDA inspection"
    Centaur Pharma Ambernath facility receives EIR from USFDA

    Centaur Pharma Ambernath facility receives EIR from USFDA

    Farhat Nasim28 Nov 2019 4:00 AM GMT
    Centaur Pharma has now received a formal EIR (Establishment Inspection Report) from USFDA stating the facility is CGMP compliant and the audit outcome...
    Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility

    Aurobindo Pharma gets 14 USFDA observations for Pashamylaram facility

    Farhat Nasim15 Nov 2019 6:43 AM GMT
    The US Food and Drug Administration (USFDA) inspected company's Unit IV, a general injectable formulation manufacturing facility situated at...
    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations

    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations

    Medical Dialogues Bureau2 Nov 2019 4:15 AM GMT
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received 2 observations from the US health regulator for...
    IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

    IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

    Medical Dialogues Bureau30 Oct 2019 8:41 AM GMT
    Mumbai: IOL Chemicals and Pharmaceuticals (IOLCP) recently received a communication from US Food and Drug Administration (USFDA) with respect to an...
    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Farhat Nasim29 Oct 2019 4:30 AM GMT
    The audit of Dr Reddy's API Srikakulam Plant (SEZ) by the United States Food and Drug Administration (USFDA) was completed on Friday, the...
    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

    Medical Dialogues Bureau28 Oct 2019 4:30 AM GMT
    "This is to inform that the US FDA had conducted an inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja, Maharashtra from...
    Shilpa Medicare Telangana facility gets EIR from USFDA

    Shilpa Medicare Telangana facility gets EIR from USFDA

    Medical Dialogues Bureau26 Oct 2019 6:16 AM GMT
    "The USFDA has concluded that the inspection classification of Jadcherla facility was "voluntary action indicated". This facility is in an acceptable...
    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Cadila Healthcare largest API manufacturing site clears USFDA inspection

    Medical Dialogues Bureau12 Oct 2019 6:11 AM GMT
    The US Food and Drug Administration (USFDA) inspected the company's active pharmaceutical ingredients (API) manufacturing facility at Dabhasa from...
    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Aurobindo Pharma Unit-7 gets 7 USFDA observations

    Medical Dialogues Bureau8 Oct 2019 9:24 AM GMT
    The United States Food and Drug Administration (USFDA) conducted a Current Good Manufacturing Practices (CGMP) inspection at the company's unit-7...
    Natco Pharma Mekaguda facility gets EIR from USFDA

    Natco Pharma Mekaguda facility gets EIR from USFDA

    Farhat Nasim1 Oct 2019 10:27 AM GMT
    Hyderabad: Drug firm Natco Pharma today said it has received Establishment Inspection Report (EIR) from the US health regulator for its Active...
    Cipla gets 12 USFDA observations for Goa facility

    Cipla gets 12 USFDA observations for Goa facility

    Medical Dialogues Bureau30 Sep 2019 9:45 AM GMT
    "The United States Food and Drug Administration (USFDA) conducted a cGMP inspection at our Goa manufacturing facility from September 16-27, 2019,"...
    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Biocon gets USFDA Form 483 with 8 observations for 2 new facilities in Bengaluru

    Medical Dialogues Bureau23 Sep 2019 4:45 AM GMT
    "At the conclusion of the inspection, we received a Form 483 with four observations for the new Drug Substance facility, three observations for the...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    X